Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Abstract Introduction Patients with type 2 diabetes (T2D) who require intensification of basal insulin therapy need treatment options that can improve their health-related quality of life (HRQoL) and translate into better outcomes
What you pay does not count toward your deductible or out-of-pocket maximum
Specifically want FDA-approved brand-name medications: The platform offers compounded formulations only
If youre dosing below 0.2mg, youre likely under the melanocortin receptor activation threshold
US$ 28.27
US$ 22.93
US$ 29.91
US$ 23.92
